RETN and metabolic disease: Disruption of this pathway by resistin has been linked to metabolic disorders, and exploring how resistin‐mediated AMPK dysregulation might affect scoliosis progression could open new avenues for research, particularly in understanding the link between metabolic dysfunction and spinal deformities.41, 42